基于心脏损伤范围对主动脉瓣狭窄进行分期分类
该研究基于PARTNER 2试验中1661例接受主动脉瓣置换的重度主动脉瓣狭窄患者,依据术前超声心动图评估的瓣外心脏损伤范围进行分期(0-4期)。结果显示,随着分期增加,1年死亡率从4.4%上升至24.5%,且心脏损伤范围是AVR术后死亡的独立预测因素(HR 1.46,95%CI 1.27-1.67,P<0.0001)。
要点
- 重度AS患者按瓣外心脏损伤范围可分为0-4期,分期越高预后越差。
- 1年死亡率随分期递增:0期4.4%,1期9.2%,2期14.4%,3期21.3%,4期24.5%。
- 心脏损伤范围是AVR术后死亡的独立预测因素(HR 1.46,95%CI 1.27-1.67)。
核心结论
- 新提出的分期分类可客观刻画AS相关的心脏损伤范围,对AVR术后临床结局具有重要预后意义。
研究设计与样本
- 汇总PARTNER 2试验中接受AVR的重度AS患者,根据术前超声心动图检测的瓣外心脏损伤进行分期:0期无瓣外损伤,1期左心室损伤,2期左心房或二尖瓣损伤,3期肺血管或三尖瓣损伤,4期右心室损伤。
- 共1661例患者具有足够超声心动图数据以进行分期。
- 采用Kaplan-Meier法比较1年结局,并用多变量Cox比例风险模型识别1年死亡预测因素。
主要发现
- 1661例患者中,0期47例(2.8%),1期212例(12.8%),2期844例(50.8%),3期413例(24.9%),4期145例(8.7%)。
- 1年死亡率:0期4.4%,1期9.2%,2期14.4%,3期21.3%,4期24.5%(Ptrend < 0.0001)。
- 心脏损伤范围与AVR术后死亡率增加独立相关(每增加一个分期HR 1.46,95%CI 1.27-1.67,P < 0.0001)。
临床怎么用
- 对重度AS患者行AVR前,可依据超声心动图评估瓣外心脏损伤范围进行分期,以辅助风险分层和预后判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: In patients with aortic stenosis (AS), risk stratification for aortic valve replacement (AVR) relies mainly on valve-related factors, symptoms and co-morbidities. We sought to evaluate the prognostic impact of a newly-defined staging classification characterizing the extent of extravalvular (extra-aortic valve) cardiac damage among patients with severe AS undergoing AVR. METHODS AND RESULTS: Patients with severe AS from the PARTNER 2 trials were pooled and classified according to the presence or absence of cardiac damage as detected by echocardiography prior to AVR: no extravalvular cardiac damage (Stage 0), left ventricular damage (Stage 1), left atrial or mitral valve damage (Stage 2), pulmonary vasculature or tricuspid valve damage (Stage 3), or right ventricular damage (Stage 4). One-year outcomes were compared using Kaplan-Meier techniques and multivariable Cox proportional hazards models were used to identify 1-year predictors of mortality. In 1661 patients with sufficient echocardiographic data to allow staging, 47 (2.8%) patients were classified as Stage 0, 212 (12.8%) as Stage 1, 844 (50.8%) as Stage 2, 413 (24.9%) as Stage 3, and 145 (8.7%) as Stage 4. One-year mortality was 4.4% in Stage 0, 9.2% in Stage 1, 14.4% in Stage 2, 21.3% in Stage 3, and 24.5% in Stage 4 (Ptrend < 0.0001). The extent of cardiac damage was independently associated with increased mortality after AVR (HR 1.46 per each increment in stage, 95% confidence interval 1.27-1.67, P < 0.0001). CONCLUSION: This newly described staging classification objectively characterizes the extent of cardiac damage associated with AS and has important prognostic implications for clinical outcomes after AVR.
引用
- Généreux P, Pibarot P, Redfors B, et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J. 2017. PMID: 29020232. doi:10.1093/eurheartj/ehx381
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。